SA
Log In
SNN
OverviewIntelligenceChart
Signal
Mixed1↑1↓
Price
1↑
Move↑+1.81%Positive session
Volume
1→
Volume→1.1× avgNormal activity
Technical
1↓
RSI↓RSI 38Momentum negative
PRICE
Prev Close
30.38
Open
30.68
Day Range30.59 – 30.97
30.59
30.97
52W Range27.97 – 38.79
27.97
38.79
27% of range
VOLUME & SIZE
Avg Volume
913.0K
FUNDAMENTALS
P/E Ratio
21.6x
EPS (TTM)
—
Div Yield
0.03%
Beta
0.77
Low vol
Performance
1D
+1.81%
5D
-1.65%
1M
-2.09%
3M
-9.40%
6M↓
-13.53%
YTD
-5.73%
1Y↑
+10.39%
Best: 1Y (+10.39%)Worst: 6M (-13.53%)
Quick Read
Trend—Insufficient MA data
Momentum
BULLISH
revenue +11% YoY · 68% gross margin
Valuation
FAIR
P/E 22x vs ~20x sector
Health
STRONG
CR 2.6 · FCF $0.98/sh
Strong Buy
Key MetricsTTM
Market Cap$13.19B
Revenue TTM$11.99B
Net Income TTM$1.04B
Free Cash Flow$1.46B
Gross Margin68.0%
Net Margin10.1%
Operating Margin16.3%
Return on Equity11.8%
Return on Assets6.1%
Debt / Equity0.63
Current Ratio2.57
EPS TTM$0.74
Alpha SignalsView Intelligence →

Intelligence analysis not yet available for this stock. Full AI-powered analysis may be available on the intelligence page.

Health Radar
3 strong2 watch1 concern
53/100
Liquidity
2.57Strong
Leverage
0.63Strong
Coverage
6.4xStrong
ROE
11.8%Watch
ROIC
9.1%Watch
Cash
$557MConcern
ANALYST COVERAGE22 analysts
HOLD
▲ +3.5%upside to target
Buy
627%
Hold
1568%
Sell
15%
6 Buy (27%)15 Hold (68%)1 Sell (5%)
Full report →
Stock Health
Composite Score
3 of 5 signals bullish
8/10
Technicals
●
RSI RangeRSI 38 — Bearish momentum
✗
Volume
●
Volume FlowAccumulation — institutional buying
✓
Fundamentals
●
Last EarningsBeat estimates
✓
●
Analyst ConsensusHold
~
●
LiquidityCurrent Ratio 2.57 — healthy liquidity
✓
Upcoming Events
EEarnings ReportMay 2, 2026
Tomorrow
DEx-Dividend DateJul 30, 2026
In 90 days
Research
Fundamentals→Financials→Analysts→Earnings→Growth→Key Metrics→Technical Analysis→Intelligence→
Technicals
Technical SetupBEARISH
Technicals →

Trend

▼ DowntrendDeath Cross · 50D trails 200D by 2.8%

-6.1% vs SMA 50 · -8.7% vs SMA 200

Momentum

RSI38.1
Momentum fading
MACD-0.74
Below zero — bearish pulse · compressing
Market Position
Price Levels
52W High
$38.79+25.4%
EMA 50
$33.19+7.3%
Current
$30.93
EMA 200
$29.83-3.6%
52W Low
$27.97-9.6%
52-Week RangeMid-range
$27.9727th %ile$38.79
Squeeze SetupVolume-based
Moderate Squeeze Setup

Accumulation pattern present — more buying days than selling over the past 20 sessions. Volume conditions support gradual price improvement.

20-Day Money Flow
Acc days:5
Dist days:4
Edge:+1 acc
Volume Context
Avg Vol (50D)892K
Recent Vol (5D)
975K+9%

Based on volume distribution analysis. Direct short interest data (short float %, days to cover) is not available in current data sources.

Earnings & Analysts

ANALYST ESTIMATES

Consensus of 9 analysts
Full estimates →
Analyst revisions:EPS↓ Revised DownRevenue↓ Revised Down

Analyst consensus estimates · Actuals replace estimates as reported

YearRevenue Est.Rev GthEPS Est.EPS GthRangeAnalysts
FY2025
$6.1B
$6.0B–$6.2B
—$1.99—
±2%
High9
FY2026(current)
$6.6B
$6.5B–$6.7B
▲ +7.3%$2.24▲ +12.6%
±1%
High9
FY2027
$7.0B
$6.8B–$7.1B
▲ +5.7%$2.48▲ +11.1%
±2%
High9
Range confidence:Tight (high)ModerateWide (low)
Earnings HistorySNN
Last 8Q
-66.1%avg beat
Beat 1 of 8 quartersMissed 7↑ Estimates rising
-87%
Q3'22
-96%
Q1'23
-87%
Q3'23
-95%
Q1'24
-69%
Q4'24
-76%
Q1'25
-22%
Q3'25
+2%
Q1'26
Beat
Miss
Estimate
Deeper color = bigger beat/miss
Analyst Activity
All ratings →
No recent activity
RBC CapitalOutperform → Sector Perform
Dec 15
DOWNGRADE
BernsteinMarket Perform
Oct 14
DOWNGRADE
UBSNeutral → Buy
Jun 5
UPGRADE
LiberumHold
May 22
DOWNGRADE
Financials
Dividends2.56% yield
+35.0% avg annual growth
Annual Yield2.56%
Semi-Annual Div.$0.4700
Est. Annual / Share$0.94
FrequencySemi-Annual
Q3'22
Q1'23
Q4'23
Q2'24
Q4'24
Q1'25
Q4'25
Q1'26

Dividend per payment — last 8 periods

INSTITUTIONAL OWNERSHIP

13-F Filings →
1
River Road Asset Management, LLC
3.2M▲
2
DEPRINCE RACE & ZOLLO INC
360K▼
3
Moran Wealth Management, LLC
173K▲
4
KORNITZER CAPITAL MANAGEMENT INC /KS
154K—
5
Henry James International Management Inc.
150K▲
6
QRG CAPITAL MANAGEMENT, INC.
80K▲
7
OPPENHEIMER ASSET MANAGEMENT INC.
66K▲
8
Perpetual Ltd
55K▲
News & Activity

SNN News

20 articles · 4h ago

About

Smith & Nephew plc, also known as Smith+Nephew, is a British multinational medical equipment manufacturing company headquartered in Watford, England.

Sector
Manufacturing
Industry
Surgical and Medical Instrument Manufacturing
CEO
Roland Diggelmann
Country
United Kingdom
Website
smith-nephew.com ↗
Vasant PadmanabhanPresident Research & Development, ENT and Emerging Markets
Paul ConnollyPresident of Global Operations
Peers— —(7 companies)
Screen sector →
SymbolPriceDay %Mkt Cap↓P/ERev GrwMarginELO
SNN◀
$30.93+1.81%$13.2B21.0+634.1%1014.0%1500
TSM
$396.06+0.57%$2.1T28.7+3296.8%4510.0%1500
HSBC
$91.86+2.89%$318.3B14.0+318.8%1510.7%1500
BABA
$131.91+1.13%$306.2B22.6+586.3%1305.9%1500
AZN
$187.37+1.17%$290.5B28.1+862.9%1745.9%1500
NVS
$147.85+3.44%$282.1B21.0+597.3%2564.4%1500
SHEL
$90.67+1.98%$256.7B14.5-591.0%668.4%1500
Sector avg—+1.85%—21.4+815.0%1902.7%1500

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance